278 related articles for article (PubMed ID: 34315044)
1. Design, synthesis and biological activity evaluation of novel scopoletin-NO donor derivatives against MCF-7 human breast cancer in vitro and in vivo.
Yu N; Li N; Wang K; Deng Q; Lei Z; Sun J; Chen L
Eur J Med Chem; 2021 Nov; 224():113701. PubMed ID: 34315044
[TBL] [Abstract][Full Text] [Related]
2. Benzo[b]furan derivatives induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway in human breast cancer cells.
Kamal A; Lakshma Nayak V; Nagesh N; Vishnuvardhan MV; Subba Reddy NV
Bioorg Chem; 2016 Jun; 66():124-31. PubMed ID: 27149364
[TBL] [Abstract][Full Text] [Related]
3. Novel Scopoletin Derivatives Kill Cancer Cells by Inducing Mitochondrial Depolarization and Apoptosis.
Shi Z; Chen L; Sun J
Anticancer Agents Med Chem; 2021; 21(14):1774-1782. PubMed ID: 33292145
[TBL] [Abstract][Full Text] [Related]
4. Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies.
Zang Y; Huang L; Chen X; Li C; Ma J; Chen X; Zhang D; Lai F
Eur J Med Chem; 2022 Dec; 244():114832. PubMed ID: 36270090
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of anilide (dicarboxylic acid) shikonin esters as antitumor agents through targeting PI3K/Akt/mTOR signaling pathway.
Ma Y; Yang X; Han H; Wen Z; Yang M; Zhang Y; Fu J; Wang X; Yin T; Lu G; Qi J; Lin H; Wang X; Yang Y
Bioorg Chem; 2021 Jun; 111():104872. PubMed ID: 33838560
[TBL] [Abstract][Full Text] [Related]
6. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
7. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro.
Yan W; Ma X; Zhao X; Zhang S
Drug Des Devel Ther; 2018; 12():3961-3972. PubMed ID: 30510404
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl)urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings.
Li W; Sun Q; Song L; Gao C; Liu F; Chen Y; Jiang Y
Eur J Med Chem; 2017 Dec; 141():721-733. PubMed ID: 29107429
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells.
Shaik AB; Rao GK; Kumar GB; Patel N; Reddy VS; Khan I; Routhu SR; Kumar CG; Veena I; Chandra Shekar K; Barkume M; Jadhav S; Juvekar A; Kode J; Pal-Bhadra M; Kamal A
Eur J Med Chem; 2017 Oct; 139():305-324. PubMed ID: 28803046
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition.
Li SS; Chen JJ; Zhang MM; Wang WX; Zhang WY; Ma C
Eur J Med Chem; 2024 May; 271():116425. PubMed ID: 38636129
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway.
Chen J; Wang T; Xu S; Zhang P; Lin A; Wu L; Yao H; Xie W; Zhu Z; Xu J
Eur J Med Chem; 2017 Jul; 135():414-423. PubMed ID: 28463784
[TBL] [Abstract][Full Text] [Related]
13. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
14. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
[TBL] [Abstract][Full Text] [Related]
15. Novel NO-releasing scopoletin derivatives induce cell death via mitochondrial apoptosis pathway and cell cycle arrest.
Shi Z; Li N; Chen C; Wang Y; Lei Z; Chen L; Sun J
Eur J Med Chem; 2020 Aug; 200():112386. PubMed ID: 32438251
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro and in vivo antitumor activity of scopoletin-cinnamic acid hybrids.
Li L; Zhao P; Hu J; Liu J; Liu Y; Wang Z; Xia Y; Dai Y; Chen L
Eur J Med Chem; 2015 Mar; 93():300-7. PubMed ID: 25703298
[TBL] [Abstract][Full Text] [Related]
17. Discovery of β-carboline-(phenylsulfonyl)furoxan hybrids as potential anti-breast cancer agents.
Hu X; Gao X; Gao G; Wang Y; Cao H; Li D; Hua H
Bioorg Med Chem Lett; 2021 May; 40():127952. PubMed ID: 33744443
[TBL] [Abstract][Full Text] [Related]
18. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.
Rabi T; Huwiler A; Zangemeister-Wittke U
Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and cytotoxic evaluation of novel scopoletin derivatives.
Shi W; Zhang J; Bao N; Guan F; Chen L; Sun J
Chem Biol Drug Des; 2018 Feb; 91(2):641-646. PubMed ID: 29052945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]